At Tricycle Day, we've been dropping psychedelic clinical trial news on you for years. We geek out on the data because it's genuinely exciting.

BUT it's important to understand that clinical trials are tightly controlled. They're designed to isolate variables and get drugs approved.

The real world doesn't work like that. Real life has comorbidities. Real life has Lexapro prescriptions. It's a lot, well, messier.

So, we're sitting down to talk about what happens when everyday people walk into a licensed center in Oregon or Colorado for a facilitated psilocybin journey.

Niko Skievaski is the CEO of Althea, the platform the vast majority of licensed facilitators and centers use to run their practices. In this conversation, Henry Winslow, founder of Tricycle Day, will pick Niko's brain on the patterns that have surfaced across thousands of real-world sessions.

Does the promise of psilocybin hold up outside a clinical trial? Or is the real world a different story?

What if I'm on antidepressants? Do I need to taper off first?

What if I'm carrying trauma? Does psilocybin help or crack things open and make it worse?

How safe is this? What are the worst-case scenarios, and how often do they occur?

Does a bigger dose mean a better outcome? What is the ideal range?

Then we'll show you how to find a high-quality psilocybin experience that meets your needs and preferences.

You're curious but stuck. You've read the research (maybe for years) but haven't booked anything.

You've counted yourself out. Because of your meds, history, age, or fears of the unknown.

You want the full picture. Benefits and risks, from someone with a view across thousands of sessions.

You have questions only a live conversation can answer. Bring them. We're saving time for Q&A. 🫠

Where: Live on Crowdcast (replay sent to all registrants)

Psilocybin in the Real World